Two days after it completed its $28.4 billion acquisition of Cerner, Oracle announced plans to build a national, anonymized health information management system.
Medtronic developed a way to reduce false alerts through its AccuRhythm™ AI algorithms. The algorithm is applied through cloud-based updates to all LINQ II™ Insertable Cardiac Monitors (ICMs) and helps improve the accuracy of information physicians receive so they can better diagnose and treat abnormal heart rhythms.
To learn more about AccuRhythm AIPlatform, please click here to download an infographic explaining how it works.
Don't miss out on this valuable opportunity to meet and discuss the latest trends and opportunities. Don't miss your chance to save with the Super Early Bird Rate.
A small Memorial Sloan Kettering Cancer Center study found that all rectal cancer patients treated with GSK drug Jemperli showed a complete response at six months—there were no detectable signs of the cancer. These early data presented at ASCO suggest that rectal cancer with a particular genetic signature might be treatable with this immunotherapy in lieu of the standard regimen of chemotherapy, radiation, and surgery.
Hospital-at-home advocates often highlight how the care modality improves the patient experience and allows hospitals to better manage capacity. There are other key benefits — such as protecting patients from hospital-acquired infections and improving caregiver's job satisfaction — that should be brought into the conversation as well, hospital executives say.
Follicular lymphoma patients in Europe now have a new treatment option. The European Commission approved Roche drug Lunsumio, a bispecific antibody designed to go after two targets to treat advanced cases of this type of cancer.
RPM as we know it today – with all its advantages – falls short. The reason? Monitoring and alerting alone cannot provide one of the most critical parts of healthcare: care itself.
No comments